I'm not buying today's Tweet referring to U. of Missouri data from years ago before the 2021-22 process "improvement" and that maybe MK just lost sight of the context of today's Tweet justifying IsoPet remaining his top priority and erroneously threw in that U. of Missouri data as a non sequitur example of very poor writing.
Any such data from before the process 2021-22 “improvement” is of no value now. FDA is only going to consider product RDGL seeks to take to human trials, not the version used before their polymer cook died in 2021.
So I take his Tweet at face value as written that the FDA “will” consider some future U. of Missouri data to determine if Radiogel is safe and effective. So it appears per the Tweet that FDA has yet to do so, confirming MK lied that FDA did so back in Dec. 2023.
Good thing you’re not running a business and multi tasking and doing more than one thing at a time, as apparently that is not your forte.
Fortunately for the rest of us, Korenko do multiple things at the same time and spearhead two different segments of the business that plan; IsoPet and pursuit of IDE approval to start human trials.
Go back to your lemonade stand. and don’t sell cookies at the same time. That would be too much diversity lol.
News 
Market Data 
Discover 
